Mark Gimbel

1.4k total citations
17 papers, 1.0k citations indexed

About

Mark Gimbel is a scholar working on Oncology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Mark Gimbel has authored 17 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 7 papers in Pathology and Forensic Medicine and 3 papers in Cancer Research. Recurrent topics in Mark Gimbel's work include Genetic factors in colorectal cancer (7 papers), Colorectal Cancer Treatments and Studies (6 papers) and Colorectal Cancer Screening and Detection (5 papers). Mark Gimbel is often cited by papers focused on Genetic factors in colorectal cancer (7 papers), Colorectal Cancer Treatments and Studies (6 papers) and Colorectal Cancer Screening and Detection (5 papers). Mark Gimbel collaborates with scholars based in United States, Australia and Syria. Mark Gimbel's co-authors include Philip B. Paty, Zhaoshi Zeng, Garrett M. Nash, MacKevin Ndubuisi, Daniel R. Nathanson, Jinru Shia, Chin‐Tung Chen, Francis Barany, Martin R. Weiser and Fade Mahmoud and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Cancer.

In The Last Decade

Mark Gimbel

16 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Gimbel United States	12	680	378	271	163	159	17	1.0k
Yihuan Xu United States	11	559 0.8×	331 0.9×	249 0.9×	103 0.6×	236 1.5×	20	1.1k
Raija Ristamäki Finland	21	760 1.1×	535 1.4×	226 0.8×	56 0.3×	230 1.4×	52	1.3k
Tae-You Kim South Korea	24	689 1.0×	678 1.8×	299 1.1×	74 0.5×	420 2.6×	48	1.5k
Darrin M. Beaupre United States	20	652 1.0×	502 1.3×	580 2.1×	152 0.9×	154 1.0×	49	1.4k
Jessica Orf United States	7	507 0.7×	545 1.4×	205 0.8×	243 1.5×	437 2.7×	9	1.3k
Maria Pia Morelli United States	19	863 1.3×	449 1.2×	272 1.0×	99 0.6×	355 2.2×	70	1.3k
S. Gail Eckhardt United States	14	779 1.1×	686 1.8×	179 0.7×	102 0.6×	470 3.0×	46	1.3k
Analía Azaro Spain	18	557 0.8×	569 1.5×	121 0.4×	107 0.7×	295 1.9×	56	1.1k
Carl C. Schimanski Germany	18	718 1.1×	309 0.8×	113 0.4×	85 0.5×	173 1.1×	28	1.1k
Eva Fernebro Sweden	19	590 0.9×	232 0.6×	183 0.7×	61 0.4×	203 1.3×	28	836

Countries citing papers authored by Mark Gimbel

Since Specialization

Citations

This map shows the geographic impact of Mark Gimbel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Gimbel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Gimbel more than expected).

Fields of papers citing papers by Mark Gimbel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Gimbel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Gimbel. The network helps show where Mark Gimbel may publish in the future.

Co-authorship network of co-authors of Mark Gimbel

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Gimbel. A scholar is included among the top collaborators of Mark Gimbel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Gimbel. Mark Gimbel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Cui, Haiyan, Mark Gimbel, Melissa A. Wilson, et al.. (2022). High GILT Expression Is Associated with Improved Survival in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibition. Cancers. 14(9). 2200–2200. 5 indexed citations

Kundranda, Madappa N., Jiaxin Niu, Boris G. Naraev, et al.. (2018). Mechanisms of resistance to BRAF and MEK inhibitors and clinical update of US Food and Drug Administration-approved targeted therapy in advanced melanoma. OncoTargets and Therapy. Volume 11. 7095–7107. 191 indexed citations

Youssef, Alexey, et al.. (2018). Thrombotic Thrombocytopenic Purpura due to Checkpoint Inhibitors. SHILAP Revista de lepidopterología. 2018. 1–4. 30 indexed citations

Khan, Sajid, M. J. Morris, Kamran Idrees, et al.. (2016). Colorectal cancer in the very young: a comparative study of tumor markers, pathology and survival in early onset and adult onset patients. Journal of Pediatric Surgery. 51(11). 1812–1817. 76 indexed citations

Gimbel, Mark, Shoshana M. Rosenberg, Zhechun Zeng, et al.. (2011). The biology of early-onset colorectal cancer: An examination of tumor markers, pathology, and survival in a large cohort of patients.. Journal of Clinical Oncology. 29(15_suppl). 3537–3537. 2 indexed citations

Chu, Carrie K., Jonathan S. Zager, Suroosh S. Marzban, et al.. (2010). Routine biopsy of cloquet's node is of limited value in sentinel node positive melanoma patients. Journal of Surgical Oncology. 102(4). 315–320. 5 indexed citations

Forslund, Ann, Sajid Khan, Li‐Xuan Qin, et al.. (2010). Improved Testing for Microsatellite Instability in Colorectal Cancer Using a Simplified 3-Marker Assay. Annals of Surgical Oncology. 17(12). 3370–3378. 17 indexed citations

Nash, Garrett M., Mark Gimbel, Jinru Shia, et al.. (2009). KRAS Mutation Correlates With Accelerated Metastatic Progression in Patients With Colorectal Liver Metastases. Annals of Surgical Oncology. 17(2). 572–578. 138 indexed citations

Nash, Garrett M., Mark Gimbel, Alfred M. Cohen, et al.. (2009). KRAS Mutation and Microsatellite Instability: Two Genetic Markers of Early Tumor Development That Influence the Prognosis of Colorectal Cancer. Annals of Surgical Oncology. 17(2). 416–424. 73 indexed citations

10.

Zeng, Zhaoshi, Martin R. Weiser, Chin‐Tung Chen, et al.. (2008). c-Met gene amplification is associated with advanced stage colorectal cancer and liver metastases. Cancer Letters. 265(2). 258–269. 146 indexed citations

11.

Gimbel, Mark, Keith A. Delman, & Jonathan S. Zager. (2008). Therapy for Unresectable Recurrent and In-Transit Extremity Melanoma. Cancer Control. 15(3). 225–232. 42 indexed citations

12.

Antonescu, Cristina R., Klaus J. Busam, Todd D. Francone, et al.. (2007). L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition. International Journal of Cancer. 121(2). 257–264. 186 indexed citations

13.

Gimbel, Mark & Philip B. Paty. (2004). A Current Perspective on Local Excision of Rectal Cancer. Clinical Colorectal Cancer. 4(1). 26–35. 15 indexed citations

14.

Gimbel, Mark, Garrett M. Nash, MacKevin Ndubuisi, et al.. (2004). Braf mutations are associated with increased mortality in colorectal cancer. Journal of the American College of Surgeons. 199(3). 92–92. 1 indexed citations

15.

Nash, Garrett M., Mark Gimbel, Jinru Shia, et al.. (2003). Automated, Multiplex Assay for High-Frequency Microsatellite Instability in Colorectal Cancer. Journal of Clinical Oncology. 21(16). 3105–3112. 35 indexed citations

16.

Lü, Qing, Yang Liu, Brian J. Long, et al.. (1999). The effect of combining aromatase inhibitors with antiestrogens on tumor growth in a nude mouse model for breast cancer. Breast Cancer Research and Treatment. 57(2). 183–192. 70 indexed citations

17.

Gimbel, Mark. (1998). Some Thoughts on the Implications of Trusted Systems for Intellectual Property Law. Stanford Law Review. 50(5). 1671–1671. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact